Erythrovirus B19 and autoimmune thyroid diseases. Review of the literature and pathophysiological hypotheses

Journal of Medical Virology

Volumn 87, Issue 1, 2015, Pages 162-169

  Page, Cyril ^a   Duverlie, Gilles ^b   Sevestre, Henri ^a   Desailloud, Rachel ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

Autoimmune thyroiditis; Erythrovirus B19; Graves' disease; Hashimoto's thyroiditis; Parvovirus B19

Indexed keywords

THYROID ANTIBODY; VIRUS ANTIBODY;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DIVISION; DISEASE ASSOCIATION; ERYTHROPARVOVIRUS; ERYTHROVIRUS B19; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN DEPENDENT DIABETES MELLITUS; NODULAR GOITER; NONHUMAN; PARVOVIRUS INFECTION; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SUBACUTE THYROIDITIS; THYROID CANCER; THYROID DISEASE; HUMAN PARVOVIRUS B19; IMMUNOLOGY; ISOLATION AND PURIFICATION; THYROID GLAND; VIROLOGY;

AUTOIMMUNE DISEASES; HUMANS; PARVOVIRUS B19, HUMAN; THYROID DISEASES; THYROID GLAND;

EID: 84909994895     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23963     Document Type: Article

References (33)

1. Adamson LA, Fowler LJ, Clare-Salzler MJ, Hobbs JA. 2011. Parvovirus B19 infection in Hashimoto's thyroiditis, papillary thyroid carcinoma, and anaplastic thyroid carcinoma. Thyroid 21:411-417.
2. Adamson LA, Fowler LJ, Ewald AS, Clare-Salzler MJ, Hobbs JA. 2013. Infection and persistence of erythrovirus B19 in benign and cancerous thyroid tissues. J Med Virol doi: 10.1002/jmv.23852. http://onlinelibrary.wiley.com/doi/10.1002/jmv.23852/abstract;jsessionid=A6360DDDE43C6034955276F6ECADCB13.f03t01
3. Bönsch C, Zuercher C, Lieby P, Kempf C, Ros C. 2010. The globoside receptor triggers structural changes in the B19 Virus capsid that facilitate virus internalization. J Virol 84:11737-11746.
4. Bouchon B, Portoukalian J, Bornet H. 1985. Alterations of the cerebroside fraction of human thyroid glycosphingolipids in Graves' disease. Biochem Int 11:415-424.
5. Brown KE. 2010. The expanding range of parvovirus which infect humans. Rev Med Virol 20:231-244.
6. Brown KE, Anderson SM, Young NS. 1993. Erythrocyte P antigen: Cellular receptor for B19 Parvovirus. Science 262:114-117.
7. Brown KE, Hibbs JR, Gallinella G, Anderson SM, Lehman ED, McCarthy P, Young NS. 1994. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 330:1192-1196.
8. Chen AY, Guan W, Lou S, Liu Z, Kleibocker S, Qiu J. 2010. Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells. J Virol 84:12385-12396.
9. Cooling LL, Koerner TA, Naides SJ. 1995. Multiple glycosphingolipids determine the tissue tropism of Parvovirus B19. J Infect Dis 172:1198-1205.
10. Desailloud R, Hober D. 2009. Viruses and thyroiditis: An update. Virol J 6:5.
11. Hemauer A, von Poblotzki A, Gigler A, Cassinotti P, Siegl G, Wolf H, Modrow S. 1996. Sequence variability among different Parvovirus B19 isolates. J Gen Virol 77:1781-1785.
12. Humar M, Dohrmann H, Stein P, Andriopoulos N, Goebel U, Roesslein M, Schmidt R, Schwer CI, Loop T, Geiger KK, Pahl HL, Pannen BH. 2008. Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Rac1 and inhibitor of kappaB kinase alpha. J Pharmacol Exp Ther 324:1037-1044.
13. Lehmann HW, Lutterbüse N, Plentz A, Akkurt I, Albers N, Hauffa BP, Hiort O, Schoenau E, Modrow S. 2008. Association of Parvovirus B19 and Hashimoto's thyroiditis in children. Viral Immunol 21:379-383.
14. Lunardi C, Tiso M, Borgato L, Nanni L, Millo R, De Sandre G, Severi AB, Puccetti A. 1998. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol 28:936-948.
15. Meyer O. 2003. Parvovirus B19 and autoimmune diseases. Joint Bone Spine 70:6-11.
16. Mori K, Yoshida K. 2010. Viral infection in induction of Hashimoto's thyroiditis: A key player or just a bystander? Curr Opin Endocrinol Diabetes Obes 17:418-424.
17. Mori K, Munakata Y, Saito T, Tani J, Nakagawa Y, Hoshikawa S, Ozaki H, Ito S, Yoshida K. 2007. Intrathyroidal persistence of human parvovirus B19 DNA in a patient with Hashimoto's thyroiditis. J Infect 55:e29-e31.
18. Mori K, Yoshida K, Ishii K, Morohoshi K, Nakagawa Y, Hoshikawa S, Ozaki H, Takahashi Y, Ito S. 2011. Experimental autoimmune thyroiditis in human parvovirus B19 transgenic mice. Autoimmunity 44:483-489.
19. Munakata Y, Kodera T, Saito T, Sasaki T. 2005a. Rheumatoid arthritis, type 1 diabetes, and Graves' disease after acute parvovirus B19 infection. Lancet 366:780.
20. Munakata Y, Saito-Ito T, Kumura-Ishii K, Huang J, Kodera T, Ishii T, Hirabashi Y, Koyanaqi Y, Sasaki T. 2005b. Ku80 autoantigen as a cellular coreceptor for human Parvovirus B19 infection. Blood 106:3449-3456.
21. Page C, Hoffmann TW, Benzerdjeb N, Duverlie G, Sevestre H, Desailloud R. 2013. Detection of erythrovirus B19 in thyroidectomy specimens from Graves' disease patients: A case-control study. J Med Virol 85:1414-1419.
22. Seishima M, Shibuya Y, Suzuki S. 2009. Hyperthyroidism associated with human parvovirus B19 infection. Clin Exp Dermatol 34:e439-e440.
23. Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur G, Meritet JF, Garbarq-Chenon A. 2002. Genetic diversity within human erythroviruses: Identification of three genotypes. J Virol 76:9124-9134.
24. Servant-Delmas A, Laperche S, Mercier M, Lefrère JJ. 2009a. Diversité génétique des Erythrovirus humains. [Genetic diversity of human erythroviruses, French]. Pathol Biol (Paris) 57:167-174.
25. Servant-Delmas A, Mercier M, Laperche S, Lefrère JJ. 2009b. Impact de la diversité génétique des Erythrovirus humains sur la sécurité infectieuse des médicaments dérivés du sang. [Genetic diversity of human erythroviruses. Consequences on infectious safety of plasma derivatives, French]. Transfus Clin Biol 16:482-488.
26. Servant-Delmas A, Lefrère JJ, Morinet F, Pillet S. 2010. Advances in human B19 erythrovirus biology. J Virol 84:9658-9665.
27. Sève P, Ferry T, Charhon A, Calvet A, Broussole C. 2004. Manifestations systémiques des infections à Parvovirus B19. [Systemic manifestations of Parvovirus B19 infections, French]. Rev Med Interne 25:740-751.
28. Vejlgaard TB, Nielsen OB. 1994. Subakutt thyreoditis ved Parvovirus B19-Infektion [Subacute thyroiditis in Parvovirus B19 infection, Danish]. Ugeskr Laeger 156:6039-6040.
29. Vlaeminck-Guillem V, D'Herbomez-Boidein M, Decoulx M, Wémeau JL. 2001. Apoptose et thyroïde: le face à Fas [Apoptosis and the thyroid: The FAS pathway, French]. Presse Med 30:74-80.
30. Wang JH, Zhang WP, Liu HX, Wang D, Li YF, Wang WQ, Wang L, He FR, Wang Z, Yan QG, Chen LW, Huang GS. 2008. Detection of human parvovirus B19 in papillary thyroid carcinoma. Br J Cancer 98:611-618.
31. Wang J, Zhang W, Liu H, Wang D, Wang W, Li Y, Wang Z, Wang L, Zhang W, Huang G. 2010. Parvovirus B19 infection associated with Hashimoto's thyroiditis in adults. J Infect 60:360-370.
32. Weigel-Kelley KA, Yoder MC, Srivastava A. 2003. Alpha5beta1 integrin as a cellular coreceptor for human Parvovirus B19: Requirement of functional activation of beta1 integrin for viral entry. Blood 102:3927-3933.
33. Young NS, Brown KE. 2004. Parvovirus B19. N Engl J Med 350:586-597.